The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000998347
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
14/07/2026
Date registered
Help: Date registered
13/08/2026
Date last updated
Help: Date last updated
13/08/2026
Date data sharing statement initially provided
Help: Data sharing statement date
13/08/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
A pilot trial of the feasibility to use pre-hospital dried plasma for patients with traumatic brain injury
Scientific title
A multi-centre randomised trial of pre-hospital treatment with freeze-dried plasma for patients with moderate to severe isolated traumatic brain injury
Additional trial identifiers [1] 317912 0
Nil
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Traumatic Brain Injury 342855 0
Bleeding 342856 0
Condition category
Condition code
Emergency medicine 338976 338976 0 0
Resuscitation
Injuries and Accidents 338977 338977 0 0
Other injuries and accidents
Blood 338978 338978 0 0
Clotting disorders

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Two units of freeze-dried plasma (total reconstituted volume of 400mL) will be infused intravenously by pre-hospital clinicians (paramedics or doctors). The infusion will be delivered as fast as possible (usually over 10 minutes), as tolerated by the intravenous access. The infusion of freeze-dried plasma, once commenced, will be continued in hospital until completion of the entire intervention dose.
All other standard care for patients with traumatic brain injury will be provided as dictated by prehospital clinical practice guidelines. This may include intubation, moderate hyperventilation and hyperosmolar therapy.
Intervention code [1] 334758 0
Treatment: Other
Description of the comparator or control
Among patients allocated to the standard care arm, management will be as dictated by prehospital clinical practice guidelines for patients with moderate to severe traumatic brain injury. This may include intubation, moderate hyperventilation and hyperosmolar therapy.
Control group
Active

Outcomes
Primary outcome [1] 346208 0
The proportion of eligible patients (meeting all the inclusion criteria and none of the exclusion criteria) who are randomised and complete the intervention. After completion of enrolment, this will be determined by a retrospective review of medical records to identify all patients who had isolated moderate to severe TBI and were transported to an eligible trauma centre. This will be assessed as a composite outcome.
Timepoint [1] 346208 0
Cumulative data will be assessed at the conclusion of the study enrolment period.
Secondary outcome [1] 465013 0
Proportion of randomised patients who complete the intervention.
Timepoint [1] 465013 0
Within 1st hour of hospital presentation
Secondary outcome [2] 465014 0
Death
Timepoint [2] 465014 0
Within 24 hours of injury
Secondary outcome [3] 465015 0
Death
Timepoint [3] 465015 0
At Hospital discharge
Secondary outcome [4] 465016 0
Hospital length of stay
Timepoint [4] 465016 0
At hospital discharge
Secondary outcome [5] 465017 0
ICU length of stay
Timepoint [5] 465017 0
At ICU discharge
Secondary outcome [6] 465018 0
Coagulation status on arrival to the ED: Measurement of the international normalised ration (INR)
Timepoint [6] 465018 0
On arrival to the trauma centre
Secondary outcome [7] 465787 0
Coagulation status on arrival to the ED: Measurement of the international normalised ration (aPTT)
Timepoint [7] 465787 0
On arrival to the trauma centre
Secondary outcome [8] 465788 0
Coagulation status on arrival to the ED: Measurement of the international normalised ration (Fibrinogen level)
Timepoint [8] 465788 0
On arrival to the trauma centre
Secondary outcome [9] 465789 0
Protocol deviations
Timepoint [9] 465789 0
At hospital discharge

Eligibility
Key inclusion criteria
1. Adult patients (age >or=18 years);
2. Injured through blunt mechanisms;
3. Patients to be transported to a participating trauma centre (The Alfred, Royal Melbourne Hospital, Princess Alexandra Hospital or Royal Brisbane and Women’s Hospital).
4. Initial Glasgow Coma Scale score <14.
5. Judged by the prehospital clinician to have moderate to severe isolated TBI
Minimum age
18 Years
Maximum age
90 Years
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
1. Extremes of age (>90 years or <18 years)
2. No intravenous access
3. Known pregnancy
4. Palliative care

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Trial packs will be consecutively numbered opaque packs with a tamper proof seal.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Random permuted blocks with a Block size of 4.
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Safety/efficacy
Statistical methods / analysis
The primary outcome of feasibility will be reported using proportions. A flow chart of all eligible patients, continuing to those that were assessed, randomised and those that completed the intervention will be presented. Proportions will be presented with 95% confidence intervals. For limited analysis of efficacy, all analyses will be undertaken on an intention-to-treat basis. It is unlikely that there will be crossover between the two arms, although it is likely that some patients will die prior to completion of the intervention. We expect to be able to capture data on the primary outcome of death without any missing data. However, in the unlikely event a subject’s survival status cannot be determined, the national registry of Births and Deaths will be interrogated. The proportion of mortality within arm will be computed and summarised using Relative Risk and reported with 95% confidence intervals. A p-value of <0.05 will be defined to be statistically significant. Given the small sample size, it is possible that despite randomisation, the two arms will not be balanced. Stata (Statacorp, College Station, TX) will be used for all analyses.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
QLD,VIC

Funding & Sponsors
Funding source category [1] 322447 0
Charities/Societies/Foundations
Name [1] 322447 0
Australian Military Medicine Association
Country [1] 322447 0
Australia
Funding source category [2] 322448 0
Charities/Societies/Foundations
Name [2] 322448 0
Queensland Brain Injury Collaborative
Country [2] 322448 0
Australia
Primary sponsor type
Government body
Name
Bayside Health
Address
Country
Australia
Secondary sponsor category [1] 325375 0
None
Name [1] 325375 0
Address [1] 325375 0
Country [1] 325375 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320939 0
Alfred Hospital Ethics Committee
Ethics committee address [1] 320939 0
Ethics committee country [1] 320939 0
Australia
Date submitted for ethics approval [1] 320939 0
15/01/2026
Approval date [1] 320939 0
15/04/2026
Ethics approval number [1] 320939 0
24/26

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 152142 0
Prof Biswadev Mitra
Address 152142 0
The Alfred Hospital, 55 Commercial Road, Melbourne VIC 3004
Country 152142 0
Australia
Phone 152142 0
+61390762782
Fax 152142 0
Email 152142 0
Contact person for public queries
Name 152143 0
Biswadev Mitra
Address 152143 0
The Alfred Hospital, 55 Commercial Road, Melbourne VIC 3004
Country 152143 0
Australia
Phone 152143 0
+610390762782
Fax 152143 0
Email 152143 0
Contact person for scientific queries
Name 152144 0
Biswadev Mitra
Address 152144 0
The Alfred Hospital, 55 Commercial Road, Melbourne VIC 3004
Country 152144 0
Australia
Phone 152144 0
+610390762782
Fax 152144 0
Email 152144 0

Data sharing statement
Will the study consider sharing individual participant data?
No
No IPD sharing reason/comment: Small pilot study; potentially re-identifiable patients



What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.